Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meyer-BPC is a pharmaceutical joint venture company based in Vietnam, established in 2001 through a partnership between Meyer Pharmaceuticals Ltd (Hong Kong) and local Vietnamese interests. The company operates a GMP-WHO certified manufacturing facility in Ben Tre Province, producing a wide range of non-beta-lactam medicines including tablets, capsules, and liquid formulations. Its portfolio covers diverse therapeutic areas such as cardiovascular health, diabetes, infectious diseases, and mental health. Meyer-BPC is active in both the domestic Vietnamese market and international export markets, particularly in Southeast Asia. The company is recognized for its commitment to international quality standards and its role in providing affordable healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meyer-BPC.